Cargando…

Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1

Dexrazoxane (DXZ) reduces cytotoxicity caused by Doxorubicin (DOX). However, the mechanism of DXZ in ferroptosis and cardiomyopathy remains unclear. This research, therefore, explores the role and mechanism of DXZ in DOX-induced ferroptosis and cardiomyopathy in rats. Kaplan–Meier survival analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Haiyan, Wang, Zheng, Liu, Zhengxia, Du, Kang, Lu, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318065/ https://www.ncbi.nlm.nih.gov/pubmed/34336950 http://dx.doi.org/10.3389/fcvm.2021.685434

Ejemplares similares

Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy
por: Zheng, Yue, et al.
Publicado: (2022)

Rosuvastatin reduces the pro-inflammatory effects of adriamycin on the expression of HMGB1 and RAGE in rats
por: Zhang, Haiyan, et al.
Publicado: (2018)

Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2023)

Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy
por: Ke, Dan, et al.
Publicado: (2023)

MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
por: Chen, Liuying, et al.
Publicado: (2021)

Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
por: Wang, Zuoxiang, et al.
Publicado: (2022)

Trpc6 Promotes Doxorubicin-Induced Cardiomyopathy in Male Mice With Pleiotropic Differences Between Males and Females
por: Norton, Nadine, et al.
Publicado: (2022)

Roles of Ferroptosis in Cardiovascular Diseases
por: Guo, Yuting, et al.
Publicado: (2022)

Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats
por: Xiang, Mi, et al.
Publicado: (2023)

Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1
por: Wang, Shu-hui, et al.
Publicado: (2023)

Current progress of ferroptosis in cardiovascular diseases
por: Zhang, Jie, et al.
Publicado: (2023)

Inhibition of ferroptosis alleviates high-power microwave-induced myocardial injury
por: Wang, Yu, et al.
Publicado: (2023)

Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021)

Sutureless Technique for Primary Total Anomalous Pulmonary Venous Connection Repair: An Updated Meta-Analysis
por: Zhao, Lu, et al.
Publicado: (2022)

Research progress on the role of ferroptosis in cardiovascular disease
por: Li, Han, et al.
Publicado: (2022)

Ferroptosis: a new strategy for cardiovascular disease
por: Wang, Yuyuan, et al.
Publicado: (2023)

Influence and risk factors of postoperative infection after surgery for ischemic cardiomyopathy
por: Wen, Bing, et al.
Publicado: (2023)

Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy
por: Luo, Weiguang, et al.
Publicado: (2023)

miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury
por: Sun, Weixin, et al.
Publicado: (2021)

Mitochondrial Cardiomyopathies
por: El-Hattab, Ayman W., et al.
Publicado: (2016)

Maslinic Acid Attenuates Ischemia/Reperfusion Injury-Induced Myocardial Inflammation and Apoptosis by Regulating HMGB1-TLR4 Axis
por: Li, Qi, et al.
Publicado: (2021)

The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
por: Chen, Zhenzhen, et al.
Publicado: (2021)

The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease
por: Zhang, Li-Li, et al.
Publicado: (2022)

Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy
por: Guo, Yaoyao, et al.
Publicado: (2021)

Expression pattern and diagnostic value of ferroptosis-related genes in acute myocardial infarction
por: Wu, Jiahe, et al.
Publicado: (2022)

Early and dynamic detection of doxorubicin induced cardiotoxicity by myocardial contrast echocardiography combined with two-dimensional speckle tracking echocardiography in rats
por: Zhang, Jun, et al.
Publicado: (2023)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Obstructive Sleep Apnea Impacts Cardiac Function in Dilated Cardiomyopathy Patients Through Circulating Exosomes
por: Gong, Hui, et al.
Publicado: (2022)

Inflammation in Metabolic Cardiomyopathy
por: Wenzl, Florian A., et al.
Publicado: (2021)

Potential ferroptosis key genes in calcific aortic valve disease
por: Li, Xiong-Zhi, et al.
Publicado: (2022)

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
por: Zhang, Guoxia, et al.
Publicado: (2022)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases
por: Teng, Teng, et al.
Publicado: (2022)

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases
por: Liu, Yuliang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v00j2dnifeb25p7edso4m9c83q